
Treatment of nasopharyngeal carcinoma with pulmonary tuberculosis and gout: A case report
Author(s) -
Lu Wu,
Mei Li,
Dingyi Liu,
Ming Jiang,
Yanyang Liu,
Zhixi Li,
Xia Wang,
Yang Yu,
Feng Luo
Publication year - 2014
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2014.2180
Subject(s) - medicine , nasopharyngeal carcinoma , gout , tuberculosis , incidence (geometry) , cancer , pulmonary tuberculosis , adverse effect , lung cancer , surgery , oncology , pathology , radiation therapy , physics , optics
In China, the incidence of nasopharyngeal carcinoma (NPC) and tuberculosis remains high. Additionally, there has been a marked increase in the prevalence of gout. In recent years, there has been an increase in the number of co-existing diseases. To the best of our knowledge, there have been no previous cases reported in the literature with regard to patients suffering from NPC complicated with pulmonary tuberculosis and gout. The present study describes the case of a 59-year-old male with this condition. The patient received a combination of anti-tumor, anti-tuberculosis and anti-gout therapies, and experienced no severe adverse reactions during treatment. At present, the patient's Eastern Cooperative Oncology Group performance status is good, there has been no local recurrence or distant metastasis of the NPC, and the pulmonary tuberculosis and gout are well controlled. The aim of this study was to provide insight into the treatment of patients suffering from co-existing conditions.